(Q48454359)

11 February 2018

title

Direct-to-consumer genetic testing for addiction susceptibility: a premature commercialisation of doubtful validity and value. (English)

1 reference

11 February 2018

1 reference

Rebecca Mathews

1

1 reference

11 February 2018

Wayne Hall

series ordinal

2

1 reference

11 February 2018

Adrian Carter

series ordinal

3

1 reference

11 February 2018

language of work or name

English

0 references

publication date

17 April 2012

1 reference

11 February 2018

published in

Addiction

1 reference

11 February 2018

volume

107

1 reference

11 February 2018

issue

12

1 reference

11 February 2018

page(s)

2069-2074

1 reference

11 February 2018

Are there genetic influences on addiction: evidence from family, adoption and twin studies

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.03836.X

Meta-analyses of ALDH2 and ADH1B with alcohol dependence in Asians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.03836.X

An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.03836.X

Predicting the effect of naltrexone and acamprosate in alcohol-dependent patients using genetic indicators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.03836.X

Genetics of dopamine receptors and drug addiction: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.03836.X

A vision for the future of genomics research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.03836.X

The burden of complex genetics in brain disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.03836.X

Approach to the genetics of alcoholism: a review based on pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.03836.X

Differential contribution of genetic variation in multiple brain nicotinic cholinergic receptors to nicotine dependence: recent progress and emerging open questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.03836.X

A variant associated with nicotine dependence, lung cancer and peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.03836.X

Carcinogenetic impact of ADH1B and ALDH2 genes on squamous cell carcinoma risk of the esophagus with regard to the consumption of alcohol, tobacco and betel quid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.03836.X

Meta-analysis of the association of the Taq1A polymorphism with the risk of alcohol dependency: a HuGE gene-disease association review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.03836.X

Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.03836.X

Targeting treatments for alcohol dependence: the pharmacogenetics of naltrexone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.03836.X

OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.03836.X

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.03836.X

Clinical and ethical considerations in pharmacogenetic testing: views of physicians in 3 "early adopting" departments of psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.03836.X

Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.03836.X

Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.03836.X

Association between mu opioid receptor gene polymorphisms and Chinese heroin addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.03836.X

Mu opioid receptor gene polymorphisms and heroin dependence in Asian populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.03836.X

A functional polymorphism within the mu-opioid receptor gene and risk for abuse of alcohol and other substances

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.03836.X

Multiple genetic tests for susceptibility to smoking do not outperform simple family history

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.03836.X

Social networkers' attitudes toward direct-to-consumer personal genome testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.03836.X

Substance use disorder genetic research: investigators and participants grapple with the ethical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.03836.X

Direct-to-consumer genetic testing: ethical-legal perspectives and practical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.03836.X

Presymptomatic and predictive genetic testing in minors: a systematic review of guidelines and position papers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.03836.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.03836.X

Promissory accounts of personalisation in the commercialisation of genomic knowledge

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.03836.X

Myths, misconceptions and myopia: searching for clarity in the debate about the regulation of consumer genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.03836.X

Genetics of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.03836.X

ASHG Statement* on Direct-to-Consumer Genetic Testing in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.03836.X

10.1111/J.1360-0443.2012.03836.X

21 January 2018

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

22510165

1 reference

11 February 2018